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Abstract
Background: Currently applied indicator organism systems, such as coliforms, are not fully
protective of public health from enteric viruses in water sources. Waterborne disease outbreaks
have occurred in systems that tested negative for coliforms, and positive coliform results do not
necessarily correlate with viral risk. It is widely recognized that bacterial indicators do not co-occur
exclusively with infectious viruses, nor do they respond in the same manner to environmental or
engineered stressors. Thus, a more appropriate indicator of health risks from infectious enteric
viruses is needed.
Presentation of the hypothesis: Torque teno virus is a small, non-enveloped DNA virus that
likely exhibits similar transport characteristics to pathogenic enteric viruses. Torque teno virus is
unique among enteric viral pathogens in that it appears to be ubiquitous in humans, elicits seemingly
innocuous infections, and does not exhibit seasonal fluctuations or epidemic spikes. Torque teno
virus is transmitted primarily via the fecal-oral route and can be assayed using rapid molecular
techniques. We hypothesize that Torque teno virus is a more appropriate indicator of viral
pathogens in drinking waters than currently used indicator systems based solely on bacteria.
Testing the hypothesis: To test the hypothesis, a multi-phased research approach is needed.
First, a reliable Torque teno virus assay must be developed. A rapid, sensitive, and specific PCR
method using established nested primer sets would be most appropriate for routine monitoring of
waters. Because PCR detects both infectious and inactivated virus, an in vitro method to assess
infectivity also is needed. The density and occurrence of Torque teno virus in feces, wastewater,
and source waters must be established to define spatial and temporal stability of this potential
indicator. Finally, Torque teno virus behavior through drinking water treatment plants must be
determined with co-assessment of traditional indicators and enteric viral pathogens to assess
whether correlations exist.
Implications of the hypothesis: If substantiated, Torque teno virus could provide a completely
new, reliable, and efficient indicator system for viral pathogen risk. This indicator would have broad
application to drinking water utilities, watershed managers, and protection agencies and would
provide a better means to assess viral risk and protect public health.
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Background
The connection between fecal contamination of drinking
water and outbreaks of disease from waterborne patho-
gens has been established for more than a century [1].
Because it would not be feasible to monitor directly for
every known pathogen, indicator organisms, which corre-
late with fecal contamination and suggest health risk, are
used instead [2,3]. In water supply systems, monitoring
for total coliforms, fecal coliforms, and E. coli is regulated
under the Total Coliform Rule (TCR) [4]. However, these
bacterial indicators are not always 100% protective of
public health, particularly from enteric viruses. Water-
borne disease outbreaks of viral etiology have occurred in
systems in which coliforms were absent, and instances of
coliform presence in violation of the TCR are not always
associated with adverse public health outcomes [5-7].
The use of coliforms as indicators of viral pathogen risk is
problematic for several reasons:
1) There is a lack of association between coliforms and
human enteric viruses in the environment. Bacterial indi-
cators have low predictive ability for enteric viruses [8,9]
and low or no correlation to viruses [10-16].
2) The fate of coliforms and viral pathogens in environ-
mental systems is disparate. Coliform bacteria are more
susceptible than enteric viruses to extremes in pH, salin-
ity, and temperature [9,17-19]. In addition, bacteria are
more easily removed by filtration through natural aquifer
systems [13,20-22]. Overall, virus persistence and mobil-
ity generally exceed that of bacteria in environmental
waters [9,23].
3) Coliforms and viral pathogens have distinct resistance
patterns in engineered treatment processes [24]24, and
infectious viruses have been found in finished waters that
are coliform negative [25,26]. Physical removal of viruses
through treatment systems, for instance by ultrafiltration
or microfiltration membranes, is more challenging than
removal of bacteria [27-32]. In addition, many enteric
viruses are more resistant than bacteria to disinfection
with chlorine and ultraviolet radiation [8,33-36].
Several alternatives to bacterial indicators have been pro-
posed. Coliphages exhibit similarities to enteric viruses
regarding environmental transport and survival [37,38].
However, coliphage survival characteristics vary by season
[39] and by coliphage group [12,40-43]. In addition, col-
iphages may continue to replicate in surviving bacterial
hosts after being shed in feces, thus exhibiting much
greater persistence than human enteric viruses in receiving
waters [9,44]. Alternatively, only a small percentage of
human or animal fecal samples test positive for col-
iphages [45,46] so these viruses may be too sparse to
detect in some environmental waters.
Some researchers have suggested enteroviruses or norovi-
ruses as indicators of other enteric viruses [47,48]. How-
ever, these viruses exhibit seasonal fluctuations and
epidemic spikes [16,49]. In addition, quantification of
infectious noroviruses in vitro has only recently been
accomplished using 3-D cell culture [50], which is well
beyond the analytical capabilities of typical water testing
laboratories. Adenovirus has been proposed as an indica-
tor because of its remarkable resistance characteristics and
lack of seasonal variability. However, this virus did not
correlate with hepatitis A virus or enteroviruses in urban
waterways [51].
We hypothesize that Torque teno virus (TTV) is a superior
indicator of enteric viruses compared to traditional bacte-
rial indicators and proposed viral indicators. TTV is an
enterically transmitted human virus, but it exhibits char-
acteristics that distinguish it from other enteric viruses.
Recent studies toward understanding the biology and
occurrence of TTV provide preliminary support for our
hypothesis.
Presentation of the hypothesis
TTV is a recently discovered non-enveloped virus with a
single-stranded, circular DNA genome [52-54]. TTV iso-
lates are remarkably variable with 47–70% divergence at
the amino acid level [55,56]. TTV divergence is unevenly
distributed across the genome; hypervariable regions exist
within the coding region [57], and the untranslated region
contains conserved regulatory sequences [58].
Initially, TTV was described as a novel hepatitis virus [52],
but it was later determined that TTV circulates in a large
proportion of healthy individuals [59-61] with an average
worldwide prevalence estimated at 80% [62,63]. The virus
appears to elicit both persistent and transient infections
[52]. Transmission of TTV is primarily by the fecal-oral
route [63], but it is detected in a variety of human tissues
and fluids, including plasma and serum [64-68]. Many
attempts have been made to assign a pathology to TTV,
but none have been substantiated. In fact, Griffiths [69]
and Simmonds et al. [70] have suggested that TTV may
constitute the first known commensal human virus.
A few investigators have tracked TTV in the environment
or in treatment systems. Their results suggest that TTV may
co-locate with various enteric viruses. Currently, little is
known about the environmental stability of TTV,
although Takayama et al. [71] demonstrated that TTV
infectivity was not lost after 95 hours of dry heat treat-
ment. Investigators suspect that TTV particles are highly
resistant to environmental stressors [72].Virology Journal 2008, 5:112 http://www.virologyj.com/content/5/1/112
Page 3 of 6
(page number not for citation purposes)
In polluted streams of Brazil, TTV was found to be spa-
tially and temporally constant [61], and the TTV positivity
rate of 92.3% paralleled the positivity rate reported by de
Paula et al. [73] for hepatitis A virus in the same geo-
graphic region. In Italy, river water samples receiving
waste treatment effluent were found to contain TTV and
other enteric viruses [72]. TTV and rotavirus occurred
either simultaneously or within 1 month's sampling
period of each other. In addition, TTV occurred 1–2
months after enterovirus was detected and simultane-
ously or within 2 months of noroviruses g1 and g2 in all
but one case.
Vaidya et al. [59] compared sewage treatment plant influ-
ent and effluent concentrations of TTV and hepatitis A and
E viruses via PCR and observed that raw sewage preva-
lence of TTV DNA was statistically similar to the preva-
lence of hepatitis E virus RNA and hepatitis A virus RNA.
Following treatment, hepatitis A virus RNA was signifi-
cantly reduced, but the reductions in TTV and hepatitis E
virus genetic material were not statistically significant.
When TTV was monitored through activated sludge waste-
water treatment plants in Japan, researchers reported that
the TTV genome was detected with 97% frequency in
influent, 18% in secondary effluent after activated sludge
but before chlorination, 24% in final effluent after chlo-
rination, and 0% in effluent for reuse following filtration
and ozonation [60]. In contrast, coliforms decreased
sequentially with each step in the treatment process, and
the concentration of coliforms did not correlate with the
number of positive TTV samples collected at any step.
As a putative indicator, TTV should be abundant where
water is not adequately treated and diarrheal disease is
common and should exist at low or undetectable levels
where water treatment leads to clean, potable water. Poor
sanitation may increase TTV transmission by the fecal-oral
route, as the countries of Bolivia and Burma – both with
high risks of waterborne disease – have TTV incidences of
82% and 96%, respectively, among otherwise healthy
individuals [74]. In contrast, TTV prevalence in the United
States is estimated to be 10% [75]. It is hypothesized that
at this prevalence, TTV would be present in most environ-
mental samples at levels high enough to be detected using
PCR [63] with the exception of contamination resulting
from single septic systems.
Testing the hypothesis
A three-phased plan of research is necessary to determine
the value of TTV as an indicator for viral pathogens.
Phase I – Develop reliable TTV assay
PCR indicates the presence/absence of a target sequence
and would yield a positive result for a non-infectious viral
particle if the particle's genetic material was intact. The
presence of viral nucleic acid at a site nevertheless indi-
cates that contamination occurred in the recent past and
suggests that the site is susceptible to future contamina-
tion [76]. The rapid nature of PCR makes it an ideal tool
for periodic monitoring of water sources.
Because viruses are present in low concentrations in envi-
ronmental waters, it is necessary to concentrate water
samples by several orders of magnitude prior to PCR anal-
ysis. However, sample concentration also may concen-
trate inhibitors of DNA polymerase. The use of hollow
fiber ultrafiltration is proposed. This method is effective
for concentrating MS2 coliphage, noroviruses, and adeno-
viruses for subsequent enumeration or PCR detection
[[77]; Sibley SD, personal communication]. The selection
of primers against conserved regions of the TTV genome is
crucial for accurately detecting all TTV isolates. In addition
to amplifying a conserved sequence, nested or seminested
PCR is proposed; this technique approaches a resolution
of one TTV genome/sample [53,62,78].
If TTV is to be used as an indicator – particularly in a treat-
ment system in which viral particles may be inactivated
but not removed – a method must be available to deter-
mine TTV infectivity. In vitro infection by TTV has been
demonstrated in activated peripheral blood mononuclear
cells and the Chang liver cell line [79-81]. Either of these
may be candidates for infectivity assessment. Chang liver
cells exhibit cytopathic effects 2–3 days after inoculation
with TTV [81] so this cell line may be useful for rapid iden-
tification of infectivity.
Phase II – Monitor TTV in sources
In order to determine the utility of TTV as an indicator, the
occurrence, density, and persistence of TTV in feces, waste-
water, and environmental waters need to be evaluated.
Geographically diverse samples should be collected dur-
ing all seasons to assess both spatial and temporal stabil-
ity. The persistence of the TTV genome has not been
described in environmental waters, but researchers have
reported that TTV DNA from fecal extracts degrades by
approximately 3 log10 within 1 week when monitored by
real-time PCR at 37°C [81]. Once these data are gathered,
the results can be compared to coliforms, coliphages, and
total culturable viruses to determine whether TTV co-
locates with other enteric viruses and/or other indicators.
Phase III – Monitor TTV through drinking water treatment
The fate of TTV through drinking water treatment proc-
esses needs to be assessed. Prior research has demon-
strated removal/inactivation of TTV through wastewater
treatment [60], but data are lacking for municipal drink-
ing waters. As with source monitoring, spatial and tempo-
ral diversity of the sampling protocol is necessary. Co-
monitoring coliforms, coliphages, and total culturableVirology Journal 2008, 5:112 http://www.virologyj.com/content/5/1/112
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viruses should be performed to demonstrate the relative
resistance of TTV to treatment effects and to determine
relationships, if any, among TTV, enteric viruses, and indi-
cators.
Implications of the hypothesis
Because of the shortcomings of traditional bacterial indi-
cator organisms to accurately indicate viral risk, novel
indicator or monitoring systems are needed. If the indica-
tor potential of TTV is substantiated, a TTV indicator sys-
tem could complement or replace traditional bacterial
indicators for the detection of human enteric viruses in
environmental samples. The ability to assess viral patho-
gen risk would be enhanced, and ultimately, public health
would be better protected.
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